Morbidity and mortality of 109 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC) performed at a community hospital

World Journal of Surgery

Volumn 34, Issue 1, 2010, Pages 62-69

  Kerscher, Alexander G ^a   Mallalieu, Jared ^b   Pitroff, Allison ^b   Kerscher, Friderike ^b   Esquivel, Jesus ^b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b Saint Agnes Healthcare ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMBINED MODALITY THERAPY; FEMALE; HOSPITAL MORTALITY; HOSPITALS, COMMUNITY; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 73649084370     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-009-0281-2     Document Type: Article

References (24)

1. VJ Verwaal S van Ruth E de Bree, et al. 2003 Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 3737 3743 10.1200/JCO.2003.04.187 14551293 (Pubitemid 46606227)
2. O Glehen F Kwiatkowski PH Sugarbaker, et al. 2004 Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol 22 3284 3292 10.1200/JCO.2004.10.012 1:STN:280:DC%2BD2cvgs1Giuw%3D%3D 15310771 (Pubitemid 41103684)
3. PH Sugarbaker D Chang 1999 Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy Ann Surg Oncol 6 727 731 10.1007/s10434-999-0727-7 1:STN:280:DC%2BD3c%2Fos1aisw%3D%3D 10622499
4. J Esquivel R Sticca P Sugarbaker, et al. 2007 Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement Society of Surgical Oncology. Ann Surg Oncol 14 128 133 1:STN:280:DC%2BD28jjtVyjsA%3D%3D
5. P Jacquet PH Sugarbaker 1996 Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis Cancer Treat Res 82 359 374 1:STN:280:DyaK2s%2Fgt1Kitw%3D%3D 8849962
6. D Elias JR Delperro L Sideris, et al. 2004 Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials Ann Surg Oncol 11 518 521 10.1245/ASO.2004.09.008 15123461 (Pubitemid 40486734)
7. PH Sugarbaker 1995 Peritonectomy procedures Ann Surg 221 29 42 1:STN:280:DyaK2M7is1OhsQ%3D%3D 7826158
8. E de Bree W Koops R Kroger, et al. 2006 Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Eur J Surg Oncol 32 65 71 10.1016/j.ejso.2005.09.016 16290055 (Pubitemid 43103990)
9. E de Bree W Koops R Kroger, et al. 2004 Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement J Surg Oncol 86 64 73 10.1002/jso.20049 15112247 (Pubitemid 38580516)
10. JS Spratt RA Adcock M Muskovin, et al. 1980 Clinical delivery system for intraperitoneal hyperthermic chemotherapy Cancer Res 40 256 260 1:STN:280:DyaL3c%2FovFOruw%3D%3D 6766084
11. JO Pelz A Stojadinovic A Nissan, et al. 2008 Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis J Surg Oncol 99 9 15 10.1002/jso.21169
12. D Elias D Goere F Blot, et al. 2007 Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43°C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients Ann Surg Oncol 14 1818 1824 10.1245/s10434-007-9348-1 17356950 (Pubitemid 46870938)
13. F Roviello D Marrelli A Neri, et al. 2006 Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity World J Surg 30 2033 2040 10.1007/s00268-006-0038-0 17006608 (Pubitemid 44655812)
14. TC Chua TD Yan A Saxena, et al. 2009 Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality Ann Surg 249 900 907 10.1097/SLA. 0b013e3181a45d86 19474692
15. S Kusamura R Younan D Baratti, et al. 2006 Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique Cancer 106 1144 1153 10.1002/cncr.21708 16456817 (Pubitemid 43297355)
16. D Elias F Blot A El Otmany, et al. 2001 Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy Cancer 92 71 76 10.1002/1097-0142(20010701)92: 1<71::AID-CNCR1293>3.0.CO;2-9 1:STN:280:DC%2BD3Mvgs12itA%3D%3D 11443611 (Pubitemid 32623042)
17. O Glehen D Osinsky E Cotte, et al. 2003 Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures Ann Surg Oncol 10 863 869 10.1245/ASO.2003.01.018 1:STN:280:DC%2BD3svmsFGhug%3D%3D 14527903 (Pubitemid 40486849)
18. U Schmidt MH Dahlke J Klempnauer, et al. 2005 Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Eur J Surg Oncol 31 53 58 10.1016/j.ejso.2004.09.011 1:STN:280:DC%2BD2M%2Fhs1Kmuw%3D%3D 15642426 (Pubitemid 40103925)
19. PH Sugarbaker R Alderman G Edwards, et al. 2006 Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy Ann Surg Oncol 13 635 644 10.1245/ASO.2006.03.079 16523363
20. B Sadeghi C Arvieux O Glehen, et al. 2000 Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study Cancer 88 358 363 10.1002/(SICI)1097-0142(20000115)88:2<358::AID- CNCR16>3.0.CO;2-O 1:STN:280:DC%2BD3c7gvVOntg%3D%3D 10640968 (Pubitemid 30051820)
21. TJ Miner J Shia DP Jaques, et al. 2005 Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy Ann Surg 241 300 308 10.1097/01.sla.0000152015.76731.1f 15650641
22. M Deraco D Baratti MG Inglese, et al. 2004 Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei Ann Surg Oncol 11 393 398 10.1245/ASO.2004.07.002 15070599 (Pubitemid 40486749)
23. P Shen EA Levine J Hall, et al. 2003 Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis Arch Surg 138 26 33 1:CAS:528:DC%2BD3sXos1eqtg%3D%3D 12511145 (Pubitemid 36055643)
24. RM Smeenk VJ Verwaal FA Zoetmulder 2007 Learning curve of combined modality treatment in peritoneal surface disease Br J Surg 94 1408 1414 10.1002/bjs.5863 1:CAS:528:DC%2BD2sXhsVGitbbO 17631678 (Pubitemid 350144391)